CDK5 and Insulin resistance: The pharmacological inhibition of MEK and ERK markedly improves insulin resistance in both obese and wild type ob/ob mice, and reversed the effects of the Cdk5 ablation, indicating that the ERK/Cdk5 axis controls the diabetogenic actions of PPARγ [5].